Ana Martínez-García
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ana Martínez-García has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Ana Frank
Neurology Service, Hospital Universitario La Paz (UAM), Madrid, Spain
10 shared publicationsFernando Valdivieso
10 shared publications- Maria Jesus Bullido
CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
10 shared publications - Eloy Rodríguez-Rodríguez
CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain
6 shared publications Isabel Sastre
Departamento de Biología Molecular and Centro de Biología Molecular Severo Ochoa (U.A.M.-C.S.I.C.), Cantoblanco, Madrid, Spain
6 shared publicationsIgnacio Mateo
5 shared publications
Latest Publications
- 1 March 2011
- Published by Elsevier in Neurobiology of Aging
- Vol. 32 (3) , 550.e5-550.e9
Genetic variations in tau-tubulin kinase-1 are linked to Alzheimer's disease in a Spanish case-control cohort
- 1 March 2011
- Published by Elsevier in Neurobiology of Aging
- Vol. 32 (3) , 550.e5-550.e9
Genetic variations in tau-tubulin kinase-1 are linked to Alzheimer's disease in a Spanish case-control cohort
- 1 March 2011
- Published by Elsevier in Neurobiology of Aging
- Vol. 32 (3) , 556.e3-556.e11
IGF-I gene variability is associated with an increased risk for AD
- 1 March 2011
- Published by Elsevier in Neurobiology of Aging
- Vol. 32 (3) , 556.e3-556.e11
IGF-I gene variability is associated with an increased risk for AD
- 7 January 2011
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 22 (4) , 1181-1187
PLA2G3, a Gene Involved in Oxidative Stress Induced Death, is Associated with Alzheimer's Disease
Oxidative stress, which plays a critical role in the pathogenesis of neurodegenerative diseases such as Alzheimer's disease (AD), is intimately linked to aging, the best established risk factor for AD. Studies in neuronal cells subjected to oxidative
- 7 January 2011
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 22 (4) , 1181-1187
PLA2G3, a Gene Involved in Oxidative Stress Induced Death, is Associated with Alzheimer's Disease
Oxidative stress, which plays a critical role in the pathogenesis of neurodegenerative diseases such as Alzheimer's disease (AD), is intimately linked to aging, the best established risk factor for AD. Studies in neuronal cells subjected to oxidative
- Open Access
- 11 August 2010
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 21 (2) , 619-625
Epistasis Between Intracellular Cholesterol Trafficking-Related Genes (NPC1 and ABCA1) and Alzheimer's Disease Risk
Aberrant cholesterol metabolism has been implicated in Alzheimer's disease (AD). Recent findings have suggested an interaction of Niemann-Pick C1 (NPC1) and ATP-binding cassette transporter A1 (ABCA1) proteins in intracellular cholesterol transport a
- 11 August 2010
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 21 (2) , 619-625
Open AccessEpistasis Between Intracellular Cholesterol Trafficking-Related Genes (NPC1 and ABCA1) and Alzheimer's Disease Risk
Aberrant cholesterol metabolism has been implicated in Alzheimer's disease (AD). Recent findings have suggested an interaction of Niemann-Pick C1 (NPC1) and ATP-binding cassette transporter A1 (ABCA1) proteins in intracellular cholesterol transport a
- 17 May 2010
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 153B (4) , 895-902
A megalin polymorphism associated with promoter activity and Alzheimer's disease risk
Elevated cerebral levels of amyloid beta‐protein (Aβ) occur in Alzheimer's disease (AD), yet only a few patients show evidence of increased Aβ production. This observation suggests that many, perhaps most, cases of AD are caused by faulty clearance of Aβ. Megalin, which plays an important role in mediating Aβ clearance, is an attractive candidate gene for genetic association with AD. To investigate this hypothesis, we analyzed the megalin gene in a population of 2,183 subjects. Genetic analysis indicated that the rs3755166 (G/A) polymorphism located in the megalin promoter associated with risk for AD, dependently of apolipoprotein E genotype. The rs3755166 AA genotype frequency was significantly greater in AD patients than in control subjects. Furthermore, the luciferase reporter assay indicated that the rs3755166 A variant has 20% less transcriptional activity than the rs3755166 G variant. This study provides strong evidence that this megalin polymorphism confers a greater risk for AD, and supports a biological role for megalin in the neurodegenerative processes involved in AD.
- 17 May 2010
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 153B (4) , 895-902
A megalin polymorphism associated with promoter activity and Alzheimer's disease risk
Elevated cerebral levels of amyloid beta‐protein (Aβ) occur in Alzheimer's disease (AD), yet only a few patients show evidence of increased Aβ production. This observation suggests that many, perhaps most, cases of AD are caused by faulty clearance of Aβ. Megalin, which plays an important role in mediating Aβ clearance, is an attractive candidate gene for genetic association with AD. To investigate this hypothesis, we analyzed the megalin gene in a population of 2,183 subjects. Genetic analysis indicated that the rs3755166 (G/A) polymorphism located in the megalin promoter associated with risk for AD, dependently of apolipoprotein E genotype. The rs3755166 AA genotype frequency was significantly greater in AD patients than in control subjects. Furthermore, the luciferase reporter assay indicated that the rs3755166 A variant has 20% less transcriptional activity than the rs3755166 G variant. This study provides strong evidence that this megalin polymorphism confers a greater risk for AD, and supports a biological role for megalin in the neurodegenerative processes involved in AD.
- Open Access
- 25 February 2010
- Published by Springer Nature in BMC Medical Genetics
- Vol. 11 (1) , 32
Caspase-1 genetic variation is not associated with Alzheimer's disease risk
Background: Interleukin (IL)-1β is a potent proinflammatory cytokine markedly overexpressed in the brains of patients with Alzheimer's disease (AD), and also involved in development of atherosclerosis and coronary artery disease. Caspase-1 (CASP1), formerly called IL-1β converting enzyme (ICE), mediates the cleavage of the inactive precursor of IL-1β into the biologically active form. CASP1 genetic variation (G+7/in6A, rs501192) has been associated with susceptibility to myocardial infarction and cardiovascular death risk. We examined the contribution of this gene to the susceptibility for AD. Methods: We examined genetic variations of CASP1 by genotyping haplotype tagging SNPs (htSNPs) (rs501192, rs556205 and rs530537) in a group of 628 Spanish AD cases and 722 controls. Results: There were no differences in the genotypic, allelic or haplotypic distributions between cases and controls in the overall analysis or after stratification by age, gender or APOE ε4 allele. Conclusion: Our negative findings in the Spanish population argue against the hypothesis that CASP1 genetic variations are causally related to AD risk.
- 25 February 2010
- Published by Springer Nature in BMC Medical Genetics
- Vol. 11 (1) , 32
Open AccessCaspase-1 genetic variation is not associated with Alzheimer's disease risk
Background: Interleukin (IL)-1β is a potent proinflammatory cytokine markedly overexpressed in the brains of patients with Alzheimer's disease (AD), and also involved in development of atherosclerosis and coronary artery disease. Caspase-1 (CASP1), formerly called IL-1β converting enzyme (ICE), mediates the cleavage of the inactive precursor of IL-1β into the biologically active form. CASP1 genetic variation (G+7/in6A, rs501192) has been associated with susceptibility to myocardial infarction and cardiovascular death risk. We examined the contribution of this gene to the susceptibility for AD. Methods: We examined genetic variations of CASP1 by genotyping haplotype tagging SNPs (htSNPs) (rs501192, rs556205 and rs530537) in a group of 628 Spanish AD cases and 722 controls. Results: There were no differences in the genotypic, allelic or haplotypic distributions between cases and controls in the overall analysis or after stratification by age, gender or APOE ε4 allele. Conclusion: Our negative findings in the Spanish population argue against the hypothesis that CASP1 genetic variations are causally related to AD risk.
- Open Access
- 26 March 2009
- Published by Wiley in Aging Cell
- Vol. 8 (2) , 128-139
A free radical‐generating system induces the cholesterol biosynthesis pathway: a role in Alzheimer's disease
Summary: Oxidative stress, which plays a critical role in the pathogenesis of neurodegenerative diseases such as Alzheimer's disease (AD), is intimately linked to aging – the best established risk factor for AD. Studies in neuronal cells subjected to oxidative stress, mimicking the situation in AD brains, are therefore of great interest. This paper reports that, in human neuronal cells, oxidative stress induced by the free radical‐generating xanthine/xanthine oxidase (X‐XOD) system leads to apoptotic cell death. Microarray analyses showed a potent activation of the cholesterol biosynthesis pathway following reductions in the cell cholesterol synthesis caused by the X‐XOD treatment; furthermore, the apoptosis was reduced by inhibiting 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase (HMGCR) expression with an interfering RNA. The potential importance of this mechanism in AD was investigated by genetic association, and it was found that HMGCR, a key gene in cholesterol metabolism and among those most strongly upregulated, was associated with AD risk. In summary, this work presents a human cell model prepared to mimic the effect of oxidative stress in neurons that might be useful in clarifying the mechanism involved in free radical‐induced neurodegeneration. Gene expression analysis followed by genetic association studies indicates a possible link among oxidative stress, cholesterol metabolism and AD.
- 26 March 2009
- Published by Wiley in Aging Cell
- Vol. 8 (2) , 128-139
Open AccessA free radical‐generating system induces the cholesterol biosynthesis pathway: a role in Alzheimer's disease
Summary: Oxidative stress, which plays a critical role in the pathogenesis of neurodegenerative diseases such as Alzheimer's disease (AD), is intimately linked to aging – the best established risk factor for AD. Studies in neuronal cells subjected to oxidative stress, mimicking the situation in AD brains, are therefore of great interest. This paper reports that, in human neuronal cells, oxidative stress induced by the free radical‐generating xanthine/xanthine oxidase (X‐XOD) system leads to apoptotic cell death. Microarray analyses showed a potent activation of the cholesterol biosynthesis pathway following reductions in the cell cholesterol synthesis caused by the X‐XOD treatment; furthermore, the apoptosis was reduced by inhibiting 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase (HMGCR) expression with an interfering RNA. The potential importance of this mechanism in AD was investigated by genetic association, and it was found that HMGCR, a key gene in cholesterol metabolism and among those most strongly upregulated, was associated with AD risk. In summary, this work presents a human cell model prepared to mimic the effect of oxidative stress in neurons that might be useful in clarifying the mechanism involved in free radical‐induced neurodegeneration. Gene expression analysis followed by genetic association studies indicates a possible link among oxidative stress, cholesterol metabolism and AD.
- 29 October 2008
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 26 (5) , 440-444
Presenilin 1 Polymorphism Associated with Alzheimer’s Disease in Apolipoprotein E4Carriers
Mutations of presenilin 1 (PSEN1) are associated with monogenic Alzheimer’s disease (AD); polymorphisms at this gene may therefore be associated with the sporadic form of the disease. In fact, recent meta-analyses and whole-genome association studies indicate PSEN1 as one of the few genes significantly associated with AD risk. Several polymorphisms have been analyzed in PSEN1. The present work examined the possible modulation of the risk of AD by a PSEN1 polymorphism (dbSNP rs3025786) located in intron 7, which we found during a denaturing gradient gel electrophoresis mutation screening of the gene, and which was previously reported as ‘suspected’ in the public databases. The study of a Spanish case-control sample of 1,183 individuals showed this polymorphism to be associated with AD in an apolipoprotein E (APOE)-specific manner: more specifically, to carry the PSEN1 C allele was associated with a decreased AD risk among carriers of the APOE4 allele. Thus, the present results reinforce the possible involvement of PSEN1 in sporadic AD.
- 29 October 2008
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 26 (5) , 440-444
Presenilin 1 Polymorphism Associated with Alzheimer’s Disease in Apolipoprotein E4Carriers
Mutations of presenilin 1 (PSEN1) are associated with monogenic Alzheimer’s disease (AD); polymorphisms at this gene may therefore be associated with the sporadic form of the disease. In fact, recent meta-analyses and whole-genome association studies indicate PSEN1 as one of the few genes significantly associated with AD risk. Several polymorphisms have been analyzed in PSEN1. The present work examined the possible modulation of the risk of AD by a PSEN1 polymorphism (dbSNP rs3025786) located in intron 7, which we found during a denaturing gradient gel electrophoresis mutation screening of the gene, and which was previously reported as ‘suspected’ in the public databases. The study of a Spanish case-control sample of 1,183 individuals showed this polymorphism to be associated with AD in an apolipoprotein E (APOE)-specific manner: more specifically, to carry the PSEN1 C allele was associated with a decreased AD risk among carriers of the APOE4 allele. Thus, the present results reinforce the possible involvement of PSEN1 in sporadic AD.
- 1 August 2008
- Published by Elsevier in Neurobiology of Aging
- Vol. 29 (8) , 1160-1166
Double stranded RNA activated EIF2 α kinase (EIF2AK2; PKR) is associated with Alzheimer's disease
- 1 August 2008
- Published by Elsevier in Neurobiology of Aging
- Vol. 29 (8) , 1160-1166
Double stranded RNA activated EIF2 α kinase (EIF2AK2; PKR) is associated with Alzheimer's disease
- 1 April 2007
- Published by Elsevier in Neurobiology of Aging
- Vol. 28 (4) , 519-523
A TAP2 genotype associated with Alzheimer's disease in APOE4 carriers
- 1 April 2007
- Published by Elsevier in Neurobiology of Aging
- Vol. 28 (4) , 519-523
A TAP2 genotype associated with Alzheimer's disease in APOE4 carriers